Clinical Trial Update: The Impact of Cytogam® on Time to Viral Load Reduction in Kidney or Kidney/Pancreas Transplant Recipients With Clinical CMV Disease [NA]

View source ↗

Summary

This clinical trial evaluated whether Cytogam shortened the time to CMV viral load reduction in kidney and kidney/pancreas transplant recipients with CMV diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Disease

Drugs mentioned

• CytoGam (Cytomegalovirus immune globulin)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Cytomegalovirus | NA | Status: COMPLETED